Tissue plasminogen activator for ischaemic stroke: Highly effective, reasonably safe and grossly underused

Medical Journal of Australia

Volumn 187, Issue 10, 2007, Pages 548-549

  Davis, Stephen M ^a   Hand, Peter J ^a   Donnan, Geoffrey A ^b  

^a Melbourne Neuroscience Institute   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ACUTE DISEASE; AMBULANCE; AUSTRALIA; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; EDITORIAL; EMERGENCY CARE; EVIDENCE BASED MEDICINE; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH EDUCATION; HUMAN; INTENSIVE CARE; MEDICAL SPECIALIST; NURSING CARE; PARAMEDICAL PERSONNEL; PATIENT MONITORING; PUBLIC HEALTH; REPERFUSION; TEAMWORK; BRAIN ISCHEMIA; STROKE;

BRAIN ISCHEMIA; FIBRINOLYTIC AGENTS; HUMANS; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 38449088527     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2007.tb01412.x     Document Type: Editorial

References (12)

1. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-774.
2. Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol 2004; 61: 1066-1070.
3. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369: 275-282.
4. Szoeke CE, Parsons MW, Butcher KS, et al. Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med J Aust 2003; 178: 324-328.
5. Bray JE, Coughlan K, Bladin C. Thrombolytic therapy for acute ischaemic stroke: successful implementation in an Australian tertiary hospital. Intern Med J 2006; 36: 483-488.
6. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655-1711.
7. Duffy BK, Phillips PA, Davis SM, et al. Evidence-based care and outcomes of acute stroke managed in hospital specialty units. Med J Aust 2003; 178: 318-323.
8. Batmanian JJ, Lam M, Matthews C, et al. A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department. Med J Aust 2007; 187: 567-570.
9. Bray JE, Martin J, Cooper G, et al. Paramedic identification of stroke: community validation of the Melbourne ambulance stroke screen. Cerebrovasc Dis 2005; 20: 28-33.
10. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2002; (1): CD000197.
11. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36: 1432-1438.
12. Davis SM, Donnan GA, Butcher KS, Parsons M. Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging. Curr Opin Neurol 2005; 18: 47-52.